Agreed, @gmac55. Of course, an option for Cryosite would be to advise the market when it enters a material clinical trials contract, be it with Imugene, Pfizer or AstraZeneca or the clutch of other 'sticky' global players it deals with daily.
Under previous, marketing-oriented management, it would. Under the present management it won't.
Again, I'd be grateful if CTE embraced the four-letter word NEWS and used it's potent ASX platform to regularly advise shareholders and potential investors on what's happening in the $1.5b Australian clinical trials industry and, importantly, what the group is achieving.
I suggest that elevating the group's profile would materially hoist it's humble market cap of ~$19.4m.
- Forums
- ASX - By Stock
- CTE
- Clinical Trial News
Clinical Trial News, page-15
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CTE (ASX) to my watchlist
|
|||||
Last
$1.13 |
Change
0.000(0.00%) |
Mkt cap ! $55.15M |
Open | High | Low | Value | Volume |
$1.13 | $1.13 | $1.13 | $170 | 150 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4484 | $1.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.12 | 3614 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4484 | 1.115 |
1 | 3982 | 1.060 |
1 | 10000 | 1.050 |
1 | 2000 | 1.030 |
1 | 22000 | 0.980 |
Price($) | Vol. | No. |
---|---|---|
1.120 | 3614 | 1 |
1.130 | 6 | 1 |
1.165 | 26333 | 1 |
1.200 | 1101 | 1 |
1.250 | 36037 | 2 |
Last trade - 11.15am 09/07/2024 (20 minute delay) ? |
Featured News
CTE (ASX) Chart |